Skip to content

Clinical trials

Completed Multiple Sclerosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Completed Country / region: Germany Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20046
20069
200714
200810
200912
20107
201110
20129
201310
20147
201511
20169
20176
20183
20198
20202
20217
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen25
Novartis Pharmaceuticals17
Bayer14
Sanofi12
Charite University, Berlin, Germany10
Merck KGaA, Darmstadt, Germany8
Teva Branded Pharmaceutical Products R&D, Inc.5
Universitätsklinikum Hamburg-Eppendorf5
Actelion4
Genzyme, a Sanofi Company4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis149
Multiple Sclerosis, Relapsing-Remitting38
Recurrence13
Fatigue4
Multiple Sclerosis, Chronic Progressive3
Optic Neuritis3
Carcinoma in Situ2
Demyelinating Diseases2
Nerve Degeneration2
Neuromyelitis Optica2

Trials

Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.